- Home
- BORR vs ZLAB Comparison
BORR vs ZLAB Comparison
Compare BORR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BORR | ZLAB |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | Bermuda | China |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BORR | ZLAB |
|---|---|---|
| Price | $6.12 | $18.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $6.25 | ★ $49.44 |
| AVG Volume (30 Days) | ★ 7.3M | 600.1K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | ★ 0.33% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $460,156,000.00 |
| Revenue This Year | N/A | $22.42 |
| Revenue Next Year | $12.39 | $29.87 |
| P/E Ratio | $20.64 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $1.55 | $15.96 |
| 52 Week High | $6.18 | $44.34 |
Technical Indicators
Market Signals| Indicator | BORR | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 45.16 |
| Support Level | $2.66 | $16.65 |
| Resistance Level | N/A | $19.70 |
| Average True Range (ATR) | 0.33 | 0.71 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 87.86 | 32.34 |
Price Performance
Historical ComparisonAbout BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.